Technology

The three major DESTINA technologies are unique and distinguishable from ALL existing enzymatic methods of nucleic acid analysis.

DGL-Tech^TM for nucleic acid analysis combines patented SMART-Bases with unique peptide nucleic acid (PNA) capture

ChemiRNA^TM Tech are small non-coding RNAs of 19–24 nucleotides in length with a big role in gene regulation

DESTINA has developed a novel platform that integrates DGL-Tech^TM with a simple colorimetric end-point